Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Finasteride shows promise for female hair loss, but more research needed.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that more research is needed to fully understand the causes of PCOS.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Early treatment helps stop hair loss in women of color.

Acne significantly affects both physical health and mental well-being.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.